Fig. 1From: Comparative efficacy and safety of PD-1/PD-L1 inhibitors in triple negative breast cancer: a systematic review and network meta-analysis of randomized controlled trialsPRISMA flowchart showing the number of studies at each stage of conducting this NMABack to article page